0001683168-22-006431.txt : 20220915
0001683168-22-006431.hdr.sgml : 20220915
20220915171158
ACCESSION NUMBER: 0001683168-22-006431
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220915
FILED AS OF DATE: 20220915
DATE AS OF CHANGE: 20220915
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Thramann Jeffrey John
CENTRAL INDEX KEY: 0001846997
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41358
FILM NUMBER: 221246426
MAIL ADDRESS:
STREET 1: 8580 STRAWBERRY LANE
CITY: NIWOT
STATE: CO
ZIP: 80503
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aclarion, Inc.
CENTRAL INDEX KEY: 0001635077
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 473324725
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 8181 ARISTA PLACE
STREET 2: STE 100
CITY: BROOMFIELD
STATE: CO
ZIP: 80021
BUSINESS PHONE: 833 275 2266
MAIL ADDRESS:
STREET 1: 8181 ARISTA PLACE
STREET 2: STE 100
CITY: BROOMFIELD
STATE: CO
ZIP: 80021
FORMER COMPANY:
FORMER CONFORMED NAME: Nocimed, Inc.
DATE OF NAME CHANGE: 20150226
4
1
ownership.xml
X0306
4
2022-09-15
0
0001635077
Aclarion, Inc.
ACON
0001846997
Thramann Jeffrey John
8181 ARISTA PLACE
SUITE 100
BROOMFIELD
CO
80021
1
1
0
0
Executive Chairman
Options for Common Stock (right to buy)
1.94
2022-09-15
4
A
0
185285
0.00
A
2031-09-27
Common Stock
185285
1390104
D
The shares underlying this option are fully vested.
In accordance with the reporting person's employment agreement, on September 27, 2021 the reporting person was previously granted 1,204,819 options with substantially identical terms to the newly granted options reported herein. The options reported herein were granted in order to satisfy the equity grant target set forth in the reporting person's employment agreement.
/s/ Jeff Thramann
2022-09-15